CLINICAL_TRIALS
trial_result
· 2011-06-10
Clinical Trial Update: A Pilot Study of Topiramate in Childhood Absence Epilepsy [Phase 2]
Summary
A Phase 2 pilot study evaluating topiramate for childhood absence epilepsy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Absence | Phase 2 | Status: COMPLETED